Authors:
Han, XM
Ou-Yang, DS
Lu, PX
Jiang, CH
Shu, Y
Chen, XP
Tan, ZR
Zhou, HH
Citation: Xm. Han et al., Plasma caffeine metabolite ratio (17X/137X) in vivo associated with G-2964A and C734A polymorphisms of human CYP1A2, PHARMACOGEN, 11(5), 2001, pp. 429-435
Authors:
Xie, HG
Dishy, V
Sofowora, G
Kim, RB
Landau, R
Smiley, RM
Zhou, HH
Wood, AJJ
Harris, P
Stein, CM
Citation: Hg. Xie et al., Arg(389)Gly beta(1)-adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivo, PHARMACOGEN, 11(3), 2001, pp. 191-197
Citation: Zq. Liu et al., Effect of the CYP2C19 oxidation polymorphism on fluoxetine metabolism in Chinese healthy subjects, BR J CL PH, 52(1), 2001, pp. 96-99
Citation: Zn. Cheng et al., Determination of estradiol metabolites in human liver microsome by high performance liquid chromatography-electrochemistry detector, ACT PHAR SI, 22(4), 2001, pp. 369-374
Authors:
Shu, Y
Cheng, ZN
Liu, ZQ
Wang, LS
Zhu, B
Huang, SL
Ou-Yang, DS
Zhou, HH
Citation: Y. Shu et al., Interindividual variations in levels and activities of cytochrome P-450 inliver microsomes of Chinese subjects, ACT PHAR SI, 22(3), 2001, pp. 283-288
Citation: Xm. Han et al., G-2964A and C734A genetic polymorphisms of CYP1A2 in Chinese population (vol 21, pg 1032, 2000), ACT PHAR SI, 22(1), 2001, pp. 14-14
Authors:
Liu, ZQ
Shu, Y
Huang, SL
Wang, LS
He, N
Zhou, HH
Citation: Zq. Liu et al., Effects of CYP2C19 genotype and CYP2C9 on fluoxetine N-demethylation in human liver macrosomes, ACT PHAR SI, 22(1), 2001, pp. 85-90
Authors:
Albarghouthi, M
Buchholz, BA
Doherty, EAS
Bogdan, FM
Zhou, HH
Barron, AE
Citation: M. Albarghouthi et al., Impact of polymer hydrophobicity on the properties and performance of DNA sequencing matrices for capillary electrophoresis, ELECTROPHOR, 22(4), 2001, pp. 737-747
Citation: Qy. Zhao et al., Pharmacokinetics of intravenous itraconazole followed by itraconazole oralsolution in patients with human immunodeficiency virus infection, J CLIN PHAR, 41(12), 2001, pp. 1319-1328
Authors:
Zhou, HH
Horowitz, A
Ledford, PC
Hubert, M
Appel-Dingemanse, S
Osborne, S
McLeod, JF
Citation: Hh. Zhou et al., The effects of tegaserod (HTF 919) on the pharmacokinetics and pharmacodynamics of digoxin in healthy subjects, J CLIN PHAR, 41(10), 2001, pp. 1131-1139
Authors:
Shu, Y
Wang, LS
Xu, ZH
He, N
Xiao, WM
Wang, W
Huang, SL
Zhou, HH
Citation: Y. Shu et al., 5-Hydroxylation of omeprazole by human liver microsomal fractions from Chinese populations related to CYP2C19 gene dose and individual ethnicity (vol295, pg 844, 2000), J PHARM EXP, 296(1), 2001, pp. 224-224
Citation: Hh. Zhou, CYP2C19 genotype determines enzyme activity and inducibility of S-mephenytoin hydroxylase, CLIN CHIM A, 313(1-2), 2001, pp. 203-208